Paper41399367
Role of Circular RNAs in Liver Diseases.
Alzahrani B. Int J Med Sci, 2026. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Role of Circular RNAs in Liver Diseases. Papers, record 41399367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41399367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| RNA, Circular | Major topic |
| Liver Diseases | Major topic |
| Humans | |
| Liver | |
| MicroRNAs | |
| Biomarkers | |
| Liver Neoplasms | |
| Gene Expression Regulation | |
| Signal Transduction |
Source PubMed
References103
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29018509 | circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis. | Oxid Med Cell Longev | 2017 | https://conductscience.org/library/papers/29018509 | PubMed |
| 2 | 36186461 | Profile analysis and functional modeling identify circular RNAs in nonalcoholic fatty liver disease as regulators of hepatic lipid metabolism. | Front Genet | 2022 | https://conductscience.org/library/papers/36186461 | PubMed |
| 3 | 32532962 | Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32532962 | PubMed |
| 4 | 33364841 | CircPVT1 Regulates Cell Proliferation, Apoptosis and Glycolysis in Hepatocellular Carcinoma via miR-377/TRIM23 Axis. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33364841 | PubMed |
| 5 | 32943922 | Exosomal Circ-ZNF652 Promotes Cell Proliferation, Migration, Invasion and Glycolysis in Hepatocellular Carcinoma via miR-29a-3p/GUCD1 Axis. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/32943922 | PubMed |
| 6 | 32077624 | hsa_circ_0000092 promotes hepatocellular carcinoma progression through up-regulating HN1 expression by binding to microRNA-338-3p. | J Cell Mol Med | 2024 | https://conductscience.org/library/papers/32077624 | PubMed |
| 7 | 28727484 | Construction and analysis of circular RNA molecular regulatory networks in liver cancer. | Cell Cycle | 2017 | https://conductscience.org/library/papers/28727484 | PubMed |
| 8 | 30053867 | circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346. | J Exp Clin Cancer Res | 2018 | https://conductscience.org/library/papers/30053867 | PubMed |
| 9 | 33982351 | Circular RNA circUbe2k promotes hepatic fibrosis via sponging miR-149-5p/TGF-β2 axis. | FASEB J | 2021 | https://conductscience.org/library/papers/33982351 | PubMed |
| 10 | 31148365 | CircMTO1 inhibits liver fibrosis via regulation of miR-17-5p and Smad7. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/31148365 | PubMed |
| 11 | 32037619 | Circ-HOMER1 enhances the inhibition of miR-1322 on CXCL6 to regulate the growth and aggressiveness of hepatocellular carcinoma cells. | J Cell Biochem | 2020 | https://conductscience.org/library/papers/32037619 | PubMed |
| 12 | 28717649 | Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis. | Biomed Res Int | 2017 | https://conductscience.org/library/papers/28717649 | PubMed |
| 13 | 31841181 | Circ_0091579 promotes proliferative ability and metastasis of liver cancer cells by regulating microRNA-490-3p. | Eur Rev Med Pharmacol Sci | 2019 | https://conductscience.org/library/papers/31841181 | PubMed |
| 14 | 35584701 | Circular RNAs: Characterization, cellular roles, and applications. | Cell | 2022 | https://conductscience.org/library/papers/35584701 | PubMed |
| 15 | 29251325 | CD90 promotes cell migration, viability and sphere‑forming ability of hepatocellular carcinoma cells. | Int J Mol Med | 2018 | https://conductscience.org/library/papers/29251325 | PubMed |
| 16 | 26600397 | Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma. | Cancer Biomark | 2016 | https://conductscience.org/library/papers/26600397 | PubMed |
| 17 | 36979495 | LncRNA and circRNA in Patients with Non-Alcoholic Fatty Liver Disease: A Systematic Review. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979495 | PubMed |
| 18 | 29458020 | CircRNA circ_0067934 promotes tumor growth and metastasis in hepatocellular carcinoma through regulation of miR-1324/FZD5/Wnt/β-catenin axis. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/29458020 | PubMed |
| 19 | 31695501 | Silencing Of hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation Of microRNA-214-3p/EZH2 Axis. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31695501 | PubMed |
| 20 | 32054840 | Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32054840 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947178 | Targeting circular RNAs to overcome therapeutic resistance in liver cancer: from mechanisms to clinical prospects. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42947178 | PubMed |
| 42746222 | Target, silence, replace: a review on RNA-based drugs in modern medicine. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42746222 | PubMed |
| 42376277 | CircRNAs in hepatic lipid metabolism: regulatory mechanisms and clinical implications. | Front Genet | 2026 | https://conductscience.org/library/papers/42376277 | PubMed |
| 42322462 | RNA-binding proteins in aging and age-related diseases: roles, mechanisms, and a large language model analysis. | Biogerontology | 2026 | https://conductscience.org/library/papers/42322462 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41399367
GET https://conductscience.org/api/papers/v1/41399367/references?page=2